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Abstract
Mapping B-cell epitopes plays an important role in vac-
cine design, immunodiagnostic tests, and antibody produc-
tion. Because the experimental determination of B-cell epi-
topes is time-consuming and expensive, there is an urgent
need for computational methods for reliable identification
of putative B-cell epitopes from antigenic sequences. In
this study, we explore the utility of evolutionary profiles
derived from antigenic sequences in improving the perfor-
mance of machine learning methods for protective linear
B-cell epitope prediction. Specifically, we compare propen-
sity scale based methods with a Naive Bayes classifier using
three different representations of the classifier input: amino
acid identities, position specific scoring matrix (PSSM) pro-
files, and dipeptide composition. We find that in predicting
protective linear B-cell epitopes, a Naive Bayes classifier
trained using PSSM profiles significantly outperforms the
propensity scale based methods as well as the Naive Bayes
classifiers trained using the amino acid identity or dipeptide
composition representations of input data.
1. Introduction
B-cell epitopes are antigenic determinants that are recog-
nized and bound by receptors (membrane-bound antibod-
ies) on the surface of B lymphocytes [26]. The identifica-
tion and characterization of B-cell epitopes plays a crucial
role in vaccine design, immunodiagnostic tests, and anti-
body production. At present, several techniques are avail-
able for experimental identification of B-cell epitopes [19].
However, their high cost prohibits their use on a genomic
scale. Hence, there is an urgent need for computational
methods for reliable prediction of B-cell epitopes [14].
There are two types of B-cell epitopes: linear (continu-
ous) and conformational (discontinuous). Linear epitopes
are short peptides, corresponding to a contiguous amino
acid sequence fragment of a protein [3, 17]. In contrast,
conformational epitopes are composed of amino acids that
are not contiguous in primary sequence, but are brought into
close proximity within the folded protein structure. Al-
though it is believed that a large majority of B-cell epi-
topes are discontinuous [34], experimental epitope identifi-
cation has focused primarily on linear B-cell epitopes [12].
Several linear B-cell epitopes in B-cell epitope databases
[25, 28] fail to produce neutralizing antibodies (and hence
fail to offer protective immunity). This has led to efforts to
compile well-characterized datasets of protective linear B-
cell epitopes, i.e., those that offer protective immunity [31].
The primary focus of this paper is on predicting protective
linear B-cell epitopes.
Classical methods of identifying potential linear B-cell
epitopes from antigenic sequences typically rely on the use
of amino acid propensity scales [23, 21, 15, 11, 24, 22,
1, 20, 29]. However, as shown by Blythe and Flower [5],
the performance of such methods is only marginally bet-
ter than that of random guessing. Hence, several methods
based on machine learning and statistical approaches have
been recently proposed for predicting linear B-cell epitopes
[18, 30, 32, 8, 31, 10, 9].
Inspired by the analysis presented by So¨llner et al. [31]
and several studies [27, 6, 13] suggesting that conserved re-
gions in antigens are good targets for developing vaccines,
we explore the utility of evolutionary profiles features, e.g.,
position-specific scoring matrices (PSSM), to improve the
performance of predicting protective linear B-cell epitopes.
We compare propensity scale based methods with a Naive
Bayes classifier using three different representations of the
classifier input: amino acid identities, position specific scor-
ing matrix (PSSM) profiles, and dipeptide composition. We
compared these methods on two datasets: a dataset of lin-
ear B-cell epitopes derived from BciPep database [28]; and
the dataset of protective linear B-cell epitopes introduced
by So¨llner et al. [31]. Our experimental results show that in
predicting protective linear B-cell epitopes, a Naive Bayes
classifier trained using PSSM profiles significantly outper-
forms the propensity scale based methods as well as the
Naive Bayes classifiers trained using the amino acid identity
or dipeptide composition representations of the data.
2. Materials and Methods
2.1 Datasets
We used two datasets in this study:
1. Protectivity dataset [31], which is, to the best of
our knowledge, the first and only available dataset
of protective linear B-cell epitopes. This dataset is
comprised of 57 non-redundant pathogen proteins ex-
tracted from IEDB database [25]. Each of these 57
antigens is annotated with a number of linear B-cell
epitopes that are classified as “leading to biological
activity”. The resulting dataset of B-cell epitopes is
believed to closely approximate a dataset of protective
linear B-cell epitopes [31].
2. BciPep dataset, a dataset of 125 non-redundant anti-
gens at 30% sequence similarity cutoff constructed
from BciPep database [28]. Peptide-based methods for
identifying linear epitopes utilize the target antigen for
deciding on a set of overlapping epitopes to be synthe-
sized on pins (PEPSCAN), on a cellulose membrane
support (SPOT), or on micro-arrays [19]. The syn-
thetic peptides are then being examined for antibody
binding. Hence, the presence of a purified antigen for
mapping of linear B-cell epitopes using peptide-based
methods is not required. Based on this observation of
the independence of antigen when identifying linear
B-cell epitopes, we label the residues in the 125 anti-
gen sequences as follows: First, we collect a set of
1230 unique B-cell epitopes included in BciPep data-
base. Then, we compare each protein sequence against
each epitope in the set of unique epitopes to find exact
matches. For each hit, we assign positive labels to anti-
gen residues included in that match. Thus, if a reported
epitope sequence is repeated in an antigen sequence,
all occurrences of that epitope will receive positive la-
bels. For example, this procedure assigns positive la-
bels to each of the 25 occurrences of the synthetic epi-
tope “TPSTPA” in the repetitive shed acute-phase anti-
gen (SAPA) from Trypanosoma cruzi. Moreover, if an
epitope sequence x is reported to be in an antigen A
but it happens that x also occurs in an antigen B and
both A and B are in our dataset, then both occurrences
of x receive positive labels.
2.2 Feature representation
In our setup, the classifier receives a nine amino-acid
window as input. A label is assigned to the instance cor-
responding to the label of the residue at the center of the
window. A positive label indicates that the target residue,
the residue at the center of the window, is included in an
epitope. A negative label denotes that the target residue is
not included in any reported epitope.
We explore three alternative representations of the nine
amino acid windows: (i) Amino Acid Identity (ID) repre-
sentation: Each 9-mer window is represented by an ordered
9-tuple of amino acids from the 20-letter amino acid alpha-
bet; (ii) PSSM representation: Each antigen sequence in
the datasets is aligned against a non-redundant dataset of
all currently known sequences using PSI-BLAST [2] with
three iterations and cut-off at 10−3. Each residue in the 9
amino acid window is then encoded using the (PSSM) ma-
trix for that residue in the resulting PSSM profile. Thus,
each 9-mer window is represented by 9× 20 feature vector;
(iii) Dipeptide composition (DC) representation: Dipep-
tide composition represent an amino acid sequence (of any
length) using the observation frequency for each possible
dipeptide in the given sequence. With 20 amino acid alpha-
bet, each 9-mer window is represented by a feature vector
of 400 dimensions which correspond to the frequencies of
occurrence of each of the 20× 20 possible dipeptides.
3. Results and Discussion
We compared the performance of the Naive Bayes clas-
sifiers using the sequence identity (NBID), PSSM profiles
(NBPSSM), and dipeptide composition (NBDC) represen-
tations of the data with five propensity scale based methods
[21, 15, 11, 24, 16] on the protectivity and BciPep datasets
using 5-fold sequence-based cross-validation [7]. The pre-
dictive performance measured by the area under the Re-
ciever Operating Characteristic (ROC) curve is summarized
in Table 1. The ROC curves are shown in Figure 1.
In predicting protective linear B-cell epitopes, Parker’s
method [21] slightly outperforms the other four propen-
sity scale based methods and even the Naive Bayes classi-
fiers evaluated using sequence identity or dipeptide compo-
sition features; and Naive Bayes classifier evaluated using
the PSSM representation of the data outperforms all other
methods. NBPSSM ROC curve dominates the ROC curves
for each of the other methods.
In predicting linear B-cell epitopes, we find that all of the
five propensity scale based methods marginally outperform
random guessing (AUC=0.5). This result is consistent with
the results of Blythe and Flower’s study on a smaller dataset
of 50 proteins [5]. Perhaps more interesting is the finding
that none of the three Naive Bayes classifiers offer improve-
ments over the propensity scale based methods. Thus, the
ROC curves for all of the methods are close to a diagonal
connecting points (0,0) and (1,1) which corresponds to a
classifier that assigns labels by random guessing.
The superior performance of a Naive Bayes classifier
evaluated using PSSM-based data representation in pre-
dicting protective linear B-cell epitopes, underscores the
functional importance of sequence conservation (previously
noted by several authors [27, 6, 13, 31]). It also suggests
that conserved regions in antigenic sequences are good can-
didates to target for developing new vaccines. This pos-
sibility needs to be further explored by applying sequence
variability analysis methods [4, 13]. It is also worth noting
that highly variable sequence residues can be functionally
important [13]. PSSM profiles contain information that can
be used to distinguish highly conserved residues from those
that are not conserved and from those that are only mod-
erately conserved. Hence, combining PSSM profiles with
machine learning methods provides a powerful tool for dis-
covering useful patterns for predicting functionally impor-
tant residues without the need for any a-priori assumptions
regarding the conservation or variability of the functional
residues.
Work in progress is aimed at further improving the per-
formance of methods for protective B-cell epitope predic-
tion by:
1. Incorporating feature selection, feature abstraction,
and dimensionality reduction methods to minimize the
deleterious effects of redundant and irrelevant features.
2. Exploring more sophisticated machine learning meth-
ods such as Support Vector Machine [33].
3. Exploring the utility of additional sequence-derived
features, e.g., predicted solvent accessibility (since lin-
ear B-cell epitopes are believed to be exposed to the
surface of the antigen).
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